ID: ALA3622442

Max Phase: Preclinical

Molecular Formula: C19H20N4O

Molecular Weight: 320.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nnc2n1-c1ccc(-c3cncc(C(C)(C)O)c3)cc1CC2

Standard InChI:  InChI=1S/C19H20N4O/c1-12-21-22-18-7-5-14-8-13(4-6-17(14)23(12)18)15-9-16(11-20-10-15)19(2,3)24/h4,6,8-11,24H,5,7H2,1-3H3

Standard InChI Key:  VTUCMYOGRJBFIC-UHFFFAOYSA-N

Associated Targets(Human)

CYP11B2 Tchem Cytochrome P450 11B2 (2325 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP11B1 Tclin Cytochrome P450 11B1 (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp11b2 Cytochrome P450 11B2 (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 320.40Molecular Weight (Monoisotopic): 320.1637AlogP: 2.96#Rotatable Bonds: 2
Polar Surface Area: 63.83Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.33CX LogP: 1.69CX LogD: 1.69
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.79Np Likeness Score: -0.80

References

1. Hoyt SB, Petrilli W, London C, Liang GB, Tata J, Hu Q, Yin L, van Koppen CJ, Hartmann RW, Struthers M, Wisniewski T, Ren N, Bopp C, Sok A, Cai TQ, Stribling S, Pai LY, Ma X, Metzger J, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Buist N, Clemas J, Zhou G, Gibson J, Maxwell CA, Lassman M, McLaughlin T, Castro-Perez J, Szeto D, Forrest G, Hajdu R, Rosenbach M, Xiong Y..  (2015)  Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.,  (8): [PMID:26288685] [10.1021/acsmedchemlett.5b00048]

Source